Nkarta, Inc. Common Stock (NKTX) is a publicly traded Healthcare sector company. As of November 9, 2026, NKTX trades at $1.46 with a market cap of $123.91M and a P/E ratio of -1.61. NKTX moved -15.61% today. Year to date, NKTX is -7.49%; over the trailing twelve months it is -12.18%. Its 52-week range spans $1.31 to $3.72. Analyst consensus is strong buy with an average price target of $11.25. Rallies surfaces NKTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for NKTX, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $1.46 |
| Market Cap | $123.91M |
| P/E Ratio | -1.61 |
| EPS | $-1.41 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.72 |
| 52-Week Low | $1.31 |
| Volume | 289.07K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-104.08M |
| Gross Margin | 0.00% |
5 analysts cover NKTX: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $11.25.